Abstract:Small 2020, 16, 2002733 DOI: 10.1002/smll.202002733 The above article, published online on 18 September 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Neville Compton; and Wiley-VCH GmbH. Following publication, concerns were raised by a third-party regarding the appearance of Figures 7d, 11a and 12a. The subsequent investigation uncovered inappropriate duplication of images (panels of Figures 7d and 12a) between this and other articles that were previously published in a different scientific context elsewhere and the manipulation of images in Figure 11a. The investigation also revealed that the animal experiments were neither conducted at, nor received ethical approval from the Department of Nuclear Medicine, West China Hospital, Sichuan University. Given the extent of the identified issues, the editors have decided to retract the article.

Retraction: Enhanced Anti-Tumor Efficacy of Hyaluronic Acid Modified Nanocomposites Combined with Sonochemotherapy Against Subcutaneous and Metastatic Breast Tumors.

Retraction: Cell Membrane Based Biomimetic Nanocomposites for Targeted Therapy of Drug Resistant EGFR-mutated Lung Cancer

Retraction: A Highly Antibacterial Polymeric Hybrid Micelle with Efficiently Targeted Anticancer Sirna Delivery and Anti-Infection in Vitro/in Vivo

Retracted: Observation of the Curative Effect of Acupuncture for Tonifying Kidney and Removing Blood Stasis Combined with Radiofrequency Surgery in Patients with NSCLC and the Diagnostic Efficacy of Combined Detection of NTx, BGP, and CYFRA21-1 in the Occurrence of Bone Metastases

Retraction: Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model.

RETRACTION: Radio-photothermal Therapy Mediated by a Single Compartment Nanoplatform Depletes Tumor Initiating Cells and Reduces Lung Metastasis in the Orthotopic 4T1 Breast Tumor Model (retraction of Vol 7, Pg 19438, 2015)

Correction: Ce6-Conjugated and Polydopamine-Coated Gold Nanostars with Enhanced Photoacoustic Imaging and Photothermal/photodynamic Therapy to Inhibit Lung Metastasis of Breast Cancer.

Retraction: A highly antibacterial polymeric hybrid micelle with efficiently targeted anticancer siRNA delivery and anti-infection <i>in vitro</i>/<i>in vivo</i>

Retraction: A Tumor-Microenvironment Fully Responsive Nano-Platform for MRI-guided Photodynamic and Photothermal Synergistic Therapy

Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Retraction of “Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial”

WITHDRAWN: Treatment of Combining Antiangiogenic Therapy and Cytotoxic Chemotherapy Reduce the Cancer Stem-Like Cell Fraction in Hepatocarcinoma Xenografts

RETRACTION: Multi-Stimuli Nanocomposite Therapeutic: Docetaxel Targeted Delivery and Synergies in Treatment of Human Breast Cancer Tumor

Retraction: PEG-poly(amino acid)s/EpCAM aptamer multifunctional nanoparticles arrest the growth and metastasis of colorectal cancer

Retracted: WNT974 Inhibits Proliferation, Induces Apoptosis, and Enhances Chemosensitivity to Doxorubicin in Lymphoma Cells by Inhibiting Wnt/b-Catenin Signaling

Retraction: A novel TMTP1-modified theranostic nanoplatform for targeted <i>in vivo</i> NIR-II fluorescence imaging-guided chemotherapy for cervical cancer

Retraction notice to "A DNA-based nanocarrier for efficient cancer therapy" [J. Pharm. Anal. 11 (2021) 330-339]

WITHDRAWN: Dual Targeting of Glioma U251 Cells and Neovasculature with a Nanoparticle Encoding Vasohibin and RGD Peptides Prevents Tumor Angiogenesis and Inhibits Tumor Growth

Tumor Microenvironment Remodeling: Biomimetic Nanomedicine Coupled with Neoadjuvant Chemotherapy to Suppress Breast Cancer Metastasis via Tumor Microenvironment Remodeling (Adv. Funct. Mater. 25/2021)

Retraction: an MSN-PEG-IP Drug Delivery System and IL13Rα2 As Targeted Therapy for Glioma.